[HTML][HTML] Immunotherapy for hepatocellular carcinoma: current status and future prospects
Z Liu, X Liu, J Liang, Y Liu, X Hou, M Zhang… - Frontiers in …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer with poor
prognosis. Surgery, chemotherapy, and radiofrequency ablation are three conventional …
prognosis. Surgery, chemotherapy, and radiofrequency ablation are three conventional …
[HTML][HTML] Pancreatic cancer in 2021: What you need to know to win
V Tonini, M Zanni - World Journal of Gastroenterology, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer is one of the solid tumors with the worst prognosis. Five-year survival rate
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
The composition of the gut microbiome can control innate and adaptive immunity and has
emerged as a key regulator of tumor growth, especially in the context of immune checkpoint …
emerged as a key regulator of tumor growth, especially in the context of immune checkpoint …
Pyroptosis remodeling tumor microenvironment to enhance pancreatic cancer immunotherapy driven by membrane anchoring photosensitizer
M Wang, M Wu, X Liu, S Shao, J Huang… - Advanced …, 2022 - Wiley Online Library
Immunotherapy, the most promising strategy of cancer treatment, has achieved promising
outcomes, but its clinical efficacy in pancreatic cancer is limited mainly due to the …
outcomes, but its clinical efficacy in pancreatic cancer is limited mainly due to the …
[HTML][HTML] LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Y Liu, M Shi, X He, Y Cao, P Liu, F Li, S Zou… - Journal of Hematology & …, 2022 - Springer
Background LncRNA-PACERR plays critical role in the polarization of tissue-associated
macrophages (TAMs). In this study, we found the function and molecular mechanism of …
macrophages (TAMs). In this study, we found the function and molecular mechanism of …
Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
L Wang, Y Liu, Y Dai, X Tang, T Yin, C Wang, T Wang… - Gut, 2023 - gut.bmj.com
Objective Innate immunity plays important roles in pancreatic ductal adenocarcinoma
(PDAC), as non-T-cell-enriched tumour. Neutrophils are major players in innate immune …
(PDAC), as non-T-cell-enriched tumour. Neutrophils are major players in innate immune …
[HTML][HTML] Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Pancreatic tumors are highly desmoplastic and immunosuppressive. Delivery and
distribution of drugs within pancreatic tumors are compromised due to intrinsic physical and …
distribution of drugs within pancreatic tumors are compromised due to intrinsic physical and …
[HTML][HTML] Artificial intelligence in pancreatic cancer
B Huang, H Huang, S Zhang, D Zhang, Q Shi, J Liu… - Theranostics, 2022 - ncbi.nlm.nih.gov
Pancreatic cancer is the deadliest disease, with a five-year overall survival rate of just 11%.
The pancreatic cancer patients diagnosed with early screening have a median overall …
The pancreatic cancer patients diagnosed with early screening have a median overall …
[HTML][HTML] Pan-cancer analysis shows that ALKBH5 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including gliomas
C Wei, B Wang, D Peng, X Zhang, Z Li, L Luo… - Frontiers in …, 2022 - frontiersin.org
Background AlkB homolog 5 (ALKBH5) is a N6-methyladenosine (m6A) demethylase
associated with the development, growth, and progression of multiple cancer types …
associated with the development, growth, and progression of multiple cancer types …
[HTML][HTML] Pancreatic cancer and immunotherapy: a clinical overview
FEF Timmer, B Geboers, S Nieuwenhuizen, M Dijkstra… - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a
dismal prognosis. While immunotherapy has been deemed a breakthrough treatment for …
dismal prognosis. While immunotherapy has been deemed a breakthrough treatment for …